
Gerald R. Ewoldt
Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1060 |
| Issued Applications | 256 |
| Pending Applications | 142 |
| Abandoned Applications | 661 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 322425
[patent_doc_number] => 07517657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Peptides for detecting anti-double stranded DNA antibody and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/129260
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 8121
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129260
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129260 | Peptides for detecting anti-double stranded DNA antibody and uses thereof | May 12, 2005 | Issued |
Array
(
[id] => 6957920
[patent_doc_number] => 20050214290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells'
[patent_app_type] => utility
[patent_app_number] => 11/128709
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12087
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214290.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128709
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128709 | Methods of blocking tissue destruction by autoreactive T cells | May 12, 2005 | Abandoned |
Array
(
[id] => 7168381
[patent_doc_number] => 20050202014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells'
[patent_app_type] => utility
[patent_app_number] => 11/129083
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12087
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202014.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129083
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129083 | Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24 | May 12, 2005 | Issued |
Array
(
[id] => 7168667
[patent_doc_number] => 20050202098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Disease therapy using dying or dead cells'
[patent_app_type] => utility
[patent_app_number] => 11/121048
[patent_app_country] => US
[patent_app_date] => 2005-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23835
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202098.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121048 | Disease therapy using dying or dead cells | May 3, 2005 | Abandoned |
Array
(
[id] => 4832823
[patent_doc_number] => 20080131370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Screening Method'
[patent_app_type] => utility
[patent_app_number] => 11/579104
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32267
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131370.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579104
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579104 | Screening Method | Apr 25, 2005 | Abandoned |
Array
(
[id] => 4948992
[patent_doc_number] => 20080305118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor'
[patent_app_type] => utility
[patent_app_number] => 10/594641
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15021
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305118.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594641 | Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor | Mar 28, 2005 | Abandoned |
Array
(
[id] => 7110606
[patent_doc_number] => 20050208061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Treatment of autoimmune diseases by oral administration of autoantigens'
[patent_app_type] => utility
[patent_app_number] => 11/090321
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9320
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208061.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090321
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090321 | Treatment of autoimmune diseases by oral administration of autoantigens | Mar 24, 2005 | Abandoned |
Array
(
[id] => 7050305
[patent_doc_number] => 20050186192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Autologous T-cell vaccines materials and methods'
[patent_app_type] => utility
[patent_app_number] => 11/060848
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6915
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186192.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060848
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060848 | Autologous T-cell vaccines materials and methods | Feb 16, 2005 | Abandoned |
Array
(
[id] => 4676187
[patent_doc_number] => 20080213817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Enhancement of Th2-Dependent and Inflammatory Response'
[patent_app_type] => utility
[patent_app_number] => 10/590042
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 30788
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590042
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590042 | Enhancement of Th2-Dependent and Inflammatory Response | Feb 16, 2005 | Abandoned |
| 11/052900 | Treatment of diabetes | Feb 8, 2005 | Abandoned |
Array
(
[id] => 259870
[patent_doc_number] => 07572592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Method for diagnosing multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/047124
[patent_app_country] => US
[patent_app_date] => 2005-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9496
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572592.pdf
[firstpage_image] =>[orig_patent_app_number] => 11047124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/047124 | Method for diagnosing multiple sclerosis | Jan 30, 2005 | Issued |
Array
(
[id] => 7252707
[patent_doc_number] => 20050142619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Antibodies to mammalian langerhans cell antigen and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/040774
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22776
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040774
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040774 | Antibodies to mammalian langerhans cell antigen and their uses | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7111144
[patent_doc_number] => 20050208599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Compositions and methods to select dendritic cells from a heterogeneous cell population'
[patent_app_type] => utility
[patent_app_number] => 11/039075
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9548
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208599.pdf
[firstpage_image] =>[orig_patent_app_number] => 11039075
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/039075 | Compositions and methods to select dendritic cells from a heterogeneous cell population | Jan 17, 2005 | Abandoned |
Array
(
[id] => 5101759
[patent_doc_number] => 20070185021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Diabetogenic epitopes'
[patent_app_type] => utility
[patent_app_number] => 10/597034
[patent_app_country] => US
[patent_app_date] => 2005-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21654
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597034 | Diabetogenic epitopes | Jan 9, 2005 | Abandoned |
Array
(
[id] => 5034183
[patent_doc_number] => 20070098722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Medicament comprising inhibitors of long pentraxin ptx3'
[patent_app_type] => utility
[patent_app_number] => 10/584292
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1614
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098722.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584292 | Medicament comprising inhibitors of long pentraxin ptx3 | Dec 20, 2004 | Abandoned |
Array
(
[id] => 4657052
[patent_doc_number] => 20080025913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Novel Anti-Dc-Sign Antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/583056
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10004
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20080025913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583056 | Novel Anti-Dc-Sign Antibodies | Dec 14, 2004 | Abandoned |
Array
(
[id] => 6982846
[patent_doc_number] => 20050152916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Antigen presenting system and methods for activation of T-cells'
[patent_app_type] => utility
[patent_app_number] => 11/005750
[patent_app_country] => US
[patent_app_date] => 2004-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 33073
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152916.pdf
[firstpage_image] =>[orig_patent_app_number] => 11005750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/005750 | Antigen presenting system and methods for activation of T-cells | Dec 6, 2004 | Abandoned |
Array
(
[id] => 5642640
[patent_doc_number] => 20060281095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => '44 human secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 11/002754
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67513
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281095.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002754 | 44 human secreted proteins | Dec 2, 2004 | Abandoned |
Array
(
[id] => 5165221
[patent_doc_number] => 20070286805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/579125
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 41708
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20070286805.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579125
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579125 | Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof | Nov 14, 2004 | Abandoned |
Array
(
[id] => 6938574
[patent_doc_number] => 20050112137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Autoantigenic fragments, methods and assays'
[patent_app_type] => utility
[patent_app_number] => 10/977955
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20859
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112137.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977955
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977955 | Autoantigenic fragments, methods and assays | Oct 28, 2004 | Abandoned |